Dr Luca Toschi, formerly a member of PRECISION ONCOLOGY CONNECT and now a leading member of LUNG CONNECT, developed this resource with COR2ED.
Dr Luca Toschi, formerly a member of PRECISION ONCOLOGY CONNECT and now a leading member of LUNG CONNECT, developed this resource with COR2ED.
AstraZeneca, BMS, Boehringer, Ingelheim, Lilly, MSD, Pfizer and Roche.
Experts discuss 2nd line+ treatment strategies in endocrine therapy-eligible patients
Expert insights on the latest data
Understanding EP-NEC, emerging treatments, and patient care strategies
Strategies to optimise the treatment experience